Detalhe da pesquisa
1.
Efficacy and safety of chimeric antigen receptor T-cells treatment in central nervous system lymphoma: a PRISMA-compliant single-arm meta-analysis.
Cancer Immunol Immunother
; 72(1): 211-221, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796863